Analyst consensus rating
Biote Analyst Rating: Strong Buy
BTMD is rated Strong Buy by 5 analysts with a $2.61 target. As of 2026-08-25.
Direct answer
Biote's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $2.61.
Forecast evidence checked August 25, 2026.
Get free Biote email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.58
- Average price target
- $2.61
- High price target
- $4.00
- Low price target
- $1.50
- Low target gap
- -5.1%
- Target upside
- +65.3%
- High target gap
- +153.2%
- Target range width
- 158.2%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- August 25, 2026
- Valid through
- September 1, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Biote?
Biote has a verified Strong Buy consensus. The same dataset has an average price target of $2.61.
How far are Biote's low and high targets from the recorded price?
The low target implies -5.1%, while the high target implies +153.2%.
How many analysts are included in Biote's consensus?
The verified consensus includes 5 analysts.
How is Biote's target upside or downside calculated?
The average target of $2.61 is divided by the recorded price of $1.58, then one is subtracted to produce +65.3%. This does not guarantee a future return.
When was Biote's analyst forecast verified?
The data was verified on 2026-08-25. The dataset is valid through 2026-09-01.